Neolpharma

Neolpharma has over five decades of experience producing prescription and OTC drugs. It operates multiple manufacturing sites in Mexico and Puerto Rico with an annual capacity of billions of units. The company has developed innovative therapies such as the epigenetic oncology drug Transkrip®, neuroprotective agents for stroke recovery, antiepileptics with cognitive benefits, and liquid dosage forms for special populations. Its research collaborations span leading Mexican academic hospitals and institutes. The group continues to expand its portfolio through R&D partnerships while maintaining a focus on affordable medicines for chronic diseases prevalent in Latin America.